Case Reports
doi: 10.1136/hrt.2006.088377.
Iron chelating in thalassaemia with left ventricular dysfunction
Affiliations
- PMID: 16973798
- PMCID: PMC1861053
- DOI: 10.1136/hrt.2006.088377
Item in Clipboard
Case Reports
Iron chelating in thalassaemia with left ventricular dysfunction
Heart.
2006 Oct.
No abstract available
Similar articles
-
Thalassaemia major: the murky story of deferiprone.BMJ. 2004 Feb 14;328(7436):358-9. doi: 10.1136/bmj.328.7436.358. BMJ. 2004. PMID: 14962851 Free PMC article. No abstract available.
-
[Iron chelators].Med Clin (Barc). 1994 May 21;102(19):739-41. Med Clin (Barc). 1994. PMID: 8041203 Spanish. No abstract available.
-
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.Lancet. 2003 Jan 11;361(9352):182-3; author reply 183-4. doi: 10.1016/S0140-6736(03)12222-2. Lancet. 2003. PMID: 12531618 No abstract available.
-
Compliance with iron chelation therapy in beta thalassaemia.Paediatr Nurs. 1998 Oct;10(8):17-8, 20. Paediatr Nurs. 1998. PMID: 10095669 Review. No abstract available.
-
[Research progress on iron chelator for malaria therapy].Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005 Aug 30;23(4):250-3. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005. PMID: 16296623 Review. Chinese. No abstract available.
Cited by
-
Extensive myocardial iron deposition in a patient with hepatitis C.Tex Heart Inst J. 2012;39(2):281-3. Tex Heart Inst J. 2012. PMID: 22740754 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
